Özkan, G. Et Al. 2013. Thrombin activatable fibrinolysis inhibitor (TAFI) levels in hypertensive patients and a comparison of the effects of amlodipine and ramipril on TAFI levels.. Clinical and experimental hypertension (New York, N.Y. : 1993) , vol.35, no.2 , 134-40.

Özkan, G., ULUSOY, Ş., SÖNMEZ, M., KARAHAN, S. C., MENTEŞE, A., KAYNAR, K., ... Bektas, Ö.(2013). Thrombin activatable fibrinolysis inhibitor (TAFI) levels in hypertensive patients and a comparison of the effects of amlodipine and ramipril on TAFI levels.. Clinical and experimental hypertension (New York, N.Y. : 1993) , vol.35, no.2, 134-40.

Özkan, Gulsum Et Al. "Thrombin activatable fibrinolysis inhibitor (TAFI) levels in hypertensive patients and a comparison of the effects of amlodipine and ramipril on TAFI levels.," Clinical and experimental hypertension (New York, N.Y. : 1993) , vol.35, no.2, 134-40, 2013

Özkan, Gulsum Et Al. "Thrombin activatable fibrinolysis inhibitor (TAFI) levels in hypertensive patients and a comparison of the effects of amlodipine and ramipril on TAFI levels.." Clinical and experimental hypertension (New York, N.Y. : 1993) , vol.35, no.2, pp.134-40, 2013

Özkan, G. Et Al. (2013) . "Thrombin activatable fibrinolysis inhibitor (TAFI) levels in hypertensive patients and a comparison of the effects of amlodipine and ramipril on TAFI levels.." Clinical and experimental hypertension (New York, N.Y. : 1993) , vol.35, no.2, pp.134-40.

@article{article, author={Gulsum Özkan Et Al. }, title={Thrombin activatable fibrinolysis inhibitor (TAFI) levels in hypertensive patients and a comparison of the effects of amlodipine and ramipril on TAFI levels.}, journal={Clinical and experimental hypertension (New York, N.Y. : 1993)}, year=2013, pages={134-40} }